Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the outcome of Mark Meador's confirmation process for FTC Commissioner by March 31, 2025?
Confirmed • 25%
Rejected • 25%
Withdrawn • 25%
Pending • 25%
Official Senate voting records or major news outlets
Trump Appoints Andrew Ferguson as FTC Chair, Nominates Mark Meador as Commissioner
Dec 10, 2024, 11:56 PM
President-elect Donald Trump announced the appointment of Andrew N. Ferguson as the next Chair of the Federal Trade Commission (FTC), succeeding Lina Khan whose term expired in September. Ferguson, a Republican commissioner sworn in on April 2, 2024, previously served as chief counsel to Senate Republican Leader Mitch McConnell and clerked for Supreme Court Justice Clarence Thomas. He is recognized for his stance against Big Tech censorship and his commitment to protecting freedom of speech, aiming to tackle perceived censorship of conservative viewpoints online. Ferguson also led Senator Chuck Grassley's team during the Justice Brett Kavanaugh confirmation process. Trump's selection has been praised by Senator Grassley, who called Ferguson an "excellent choice to take on big tech and big pharma." Trump described Ferguson as "the most America First, and pro-innovation FTC Chair in our country's history." In addition, Trump nominated Mark R. Meador, a partner at Kressin Meador Powers LLC and former Deputy Chief Counsel for Antitrust and Competition Policy to Senator Mike Lee, to be a Commissioner on the FTC. Meador is regarded as a leading conservative legal scholar in antitrust law.
View original story
Confirmed • 33%
Rejected • 33%
Nomination Withdrawn • 34%
Confirmed • 33%
Rejected • 33%
Nomination Withdrawn • 34%
Confirmed with strong majority • 25%
Confirmed with narrow majority • 25%
Not confirmed • 25%
Confirmation delayed • 25%
Confirmed with majority • 33%
Confirmed with narrow margin • 33%
Not confirmed • 34%
Confirmed • 33%
Rejected • 33%
Withdrawn • 34%
Confirmed • 33%
Rejected • 33%
Withdrawn • 34%
Confirmed • 25%
Rejected • 25%
Withdrawn • 25%
No Decision • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Consumer Protection • 25%
Pharmaceutical Regulation • 25%
Big Tech Regulation • 25%
Antitrust Enforcement • 25%